Existing Medicines
Showing 1 - 25 of 6,094
Optimising Pharmacist-led Medication Reviews in Primary Care
Not yet recruiting
- ALL, Adult
- Medication review
- (no location specified)
Jun 22, 2023
Hypertension Trial in United Kingdom (OE 10 mg amlodipine besylate tablet, OE 200 mg celecoxib capsule, Matched for OE
Completed
- Hypertension
- OE 10 mg amlodipine besylate tablet
- +3 more
-
Bath, United Kingdom
- +8 more
Sep 27, 2019
Avelumab First-Line Maintenance in Canadian People With Advanced
Not yet recruiting
- Urinary Bladder Neoplasms
- +3 more
- Avelumab first-line maintenance
-
Mississauga, Ontario, CanadaBayshore Specialty Rx
Jan 24, 2023
Will Permit Sites to Proactively Assess TAA, HLA and HPV-16
Terminated
- Head and Neck Cancer
- +7 more
- Tumor Profiling
-
Scottsdale, Arizona
- +2 more
Dec 2, 2022
Epilepsy Trial in Dhulikhel (Sodium valproate and valproic acid extended release tablet)
Not yet recruiting
- Epilepsy
- Sodium valproate and valproic acid extended release tablet
-
Dhulikhel, Bagmati, Nepal
- +1 more
Dec 6, 2022
Pneumonia, COPD Asthma, COPD Exacerbation Trial in Istanbul (Intervention groups)
Completed
- Pneumonia
- +2 more
- Intervention groups
-
Istanbul, TurkeyBezmialem Vakif University
Oct 3, 2022
Type 2 Diabetes Treated With Insulin, Hypoglycemia, Primary Health Care Trial in United States (Conversation Aid, Attention
Recruiting
- Type 2 Diabetes Treated With Insulin
- +3 more
- Conversation Aid
- Attention Control Educational Handout
-
San Francisco, California
- +3 more
Jan 27, 2023
Bacterial Infections Trial in Quezon City (Monolaurin, Mupirocin ointment)
Completed
- Bacterial Infections
- Monolaurin
- Mupirocin ointment
-
Quezon City, NCR, PhilippinesV. Luna Medical Center
Sep 21, 2023
Lung Cancer Patient ExperiEnce in the Real-World Setting
Recruiting
- Lung Cancer Patients
- Caregivers
- There are no interventions in this study. All participants complete online surveys.
-
Bethesda, MarylandLUNGevity Foundation
Apr 26, 2023
Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)
Recruiting
- Solid Tumor
- Haematological Malignancy
- Alectinib
- +4 more
-
Belfast, United Kingdom
- +24 more
Jan 31, 2023
Oncology, Chemotherapeutic Toxicity, Metastatic Solid Tumor Trial in Minneapolis (Chemotherapy toxicity tool, Oncology
Active, not recruiting
- Oncology
- +2 more
- Chemotherapy toxicity tool
- Oncology Consultation
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Mar 30, 2023
Healthy Volunteer Trial in Leeds (REGN7508 (IV), REGN7508 (SC), Matching Placebo (IV))
Recruiting
- Healthy Volunteer
- REGN7508 (IV)
- +3 more
-
Leeds, United KingdomLabcorp Clinical Research Unit
Jan 30, 2023
Called RegoFlex EU, to Learn More About Use of Stivarga at
Completed
- Metastatic Colorectal Cancer
- Retrospective patient chart review
-
Whippany, New JerseyMany locations
Jan 24, 2023
Assess Maternal and Fetal Outcomes After Taking Prucalopride
Recruiting
- Constipation
- Pregnancy
-
Boston, MassachusettsHarvard T.H. Chan School of Public Health
Feb 14, 2022
Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication Trial (mHealth Messaging Intervention Group)
Not yet recruiting
- Transplant;Failure,Kidney
- +4 more
- mHealth Messaging Intervention Group
- (no location specified)
Nov 4, 2022
Burden of Illness and Treatment Patterns in Teenagers and
Recruiting
- Hereditary Angioedema
-
Warszawa, Poland
- +4 more
May 6, 2022
COVID-19 Trial in Canterbury (Sambucol® Black Elderberry Original (Sambucus nigra) Liquid, Placebo for Sambucol® Black
Completed
- COVID-19
- Sambucol® Black Elderberry Original (Sambucus nigra) Liquid
- Placebo for Sambucol® Black Elderberry Original (Sambucus nigra)
-
Canterbury, Kent, United KingdomEast Kent Hospitals University NHS Foundation trust
Aug 4, 2022
EHR Precision Drug Treatment in Neonates
Active, not recruiting
- Pain, Acute
- Pain, Chronic
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 7, 2022
End of Life Trial (Psilocybin-assisted therapy within a community of practice model (group administered))
Not yet recruiting
- End of Life
- Psilocybin-assisted therapy within a community of practice model (group administered)
- (no location specified)
Jul 14, 2023
Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)
Active, not recruiting
- Neoplasms
- Carcinoma, Non-Small-Cell Lung
- BI 754111
- BI 754091
-
Miami, Florida
- +14 more
Jan 9, 2023
B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Odronextamab
- +8 more
- (no location specified)
Aug 7, 2023
Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United
Recruiting
- Relapsing Multiple Sclerosis
- +2 more
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
-
Palo Alto, California
- +20 more
Jan 25, 2023
Bacteriophage Therapy of Difficult-to-treat Infections
Completed
- Bacterial Infections
- Bacteriophage therapy
- (no location specified)
Aug 10, 2022
Learn About First and Later Lines of Medicines in Treating
Completed
- Metastatic Renal Cell Carcinoma
-
New York, New YorkPfizer Headquarters
May 12, 2023